ARTICLE | Clinical News
ME-344: Phase I started
June 4, 2012 7:00 AM UTC
Marshall Edwards began an open-label, dose-escalation, U.S. Phase I trial to evaluate once-weekly 1.2, 2.5, 5, 10 and 20 mg/kg IV ME-344 for the first 3 weeks of a 28-day cycle in up to 24 patients. P...